The timeout came about two and a half minutes into the second half Tuesday night, with Duke’s 24-point halftime lead down to ...

The Hornets are sending Richards and a second-round pick to Phoenix for Josh Okogie and three second-round picks, league ...

Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.

Duke Graduate and Professional Student Government heard a presentation from University administrators addressing Duke's ...

Freshman Kon Knueppel had season highs of 25 points and six 3-pointers to help No. 3 Duke beat Miami 89-54 on Tuesday night ...

Duke poured in 17 3-pointers, including six from freshman Kon Knueppel, as the Blue Devils rolled over last-place Miami in ...

Following freshman Cooper Flagg’s record-setting performance over the weekend, Duke men’s basketball is looking to close out ...

Miami is elite inside the arc shooting 58.3 percent. Duke is third nationally holding opponents to 40 percent on two-point field goal attempts. Matthew Cleveland has to continue scoring well for Miami ...

It’s a kind of control that no one has ever tried before in patients,” Tune’s chief scientific officer said Monday.

Durham, North Carolina; Tuesday, 9 p.m. EST BETMGM SPORTSBOOK LINE: Blue Devils -23; over/under is 147.5 BOTTOM LINE: No.

Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.